{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":3,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":3,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"41fdbd2dc2bc","filters":{"venue":"Drug Discovery Today Therapeutic Strategies"}},"results":[{"id":"W2066470480","doi":"10.1016/j.ddstr.2008.05.005","title":"Cardiovascular consequences of obesity","year":2008,"lang":"en","type":"article","venue":"Drug Discovery Today Therapeutic Strategies","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institut universitaire de cardiologie et de pneumologie de Québec","funders":"","keywords":"Obesity; Medicine; Diabetes mellitus; Disease; Body mass index; Metabolic syndrome; Obstructive sleep apnea; Sleep apnea; Type 2 diabetes; Developed country; Internal medicine; Environmental health; Endocrinology; Population","authors":[{"name":"Paul Poirier","is_ca":true},{"name":"Robert H. Eckel","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02426041976850105,"gpt":0.248128240180448,"spread":0.2238678204119469,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004880115,0.0003145113,0.001063866,0.000131469,0.000156704,0.00006104081,0.0002216784,0.0001151219,0.00008028068],"category_scores_gemma":[0.00002893532,0.0002514086,0.0013002,0.0002979489,0.00102222,0.0005455859,0.00004232142,0.0002280089,0.00003046832],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004827184,"about_ca_system_score_gemma":0.0006397128,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005143149,"about_ca_topic_score_gemma":0.0000723182,"domain_scores_codex":[0.9977312,0.0001885868,0.0004159984,0.0004423067,0.0008142279,0.0004076826],"domain_scores_gemma":[0.9985748,0.00008642236,0.000113269,0.0009601991,0.0001544327,0.000110902],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.003459897,0.006602671,0.1567651,0.006186236,0.09296895,0.004411092,0.03281217,0.01073071,0.06117188,0.08756699,0.004400526,0.5329238],"study_design_scores_gemma":[0.007882646,0.0009711058,0.6205934,0.0007762359,0.004388437,0.001444779,0.01992227,0.00007237287,0.2660082,0.01757194,0.05849932,0.00186927],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.947465,0.03539525,0.001003541,0.000160929,0.0003006077,0.0005498054,0.00002697781,0.0001112405,0.01498663],"genre_scores_gemma":[0.995437,0.00289898,0.0001958924,0.0001647494,0.0002088159,0.00003946364,0.00002483647,0.00003691839,0.0009932994],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5310545,"threshold_uncertainty_score":0.9999938,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1979457312","doi":"10.1016/j.ddstr.2013.11.001","title":"Manipulating angiotensin metabolism with angiotensin converting enzyme 2 (ACE2) in heart failure","year":2012,"lang":"en","type":"review","venue":"Drug Discovery Today Therapeutic Strategies","topic":"Renin-Angiotensin System Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research; Alberta Innovates; Heart and Stroke Foundation of Canada","keywords":"Angiotensin-converting enzyme 2; Heart failure; Angiotensin II; Angiotensin II receptor type 1; Pressure overload; Internal medicine; Receptor; Endocrinology; Renin–angiotensin system; Ventricular remodeling; Medicine; Muscle hypertrophy; Angiotensin-converting enzyme; Myocardial infarction; Angiotensin 1; Fibrosis; Blood pressure; Pharmacology; Cardiac hypertrophy; Disease","authors":[{"name":"Vaibhav B. Patel","is_ca":true},{"name":"Brendan Putko","is_ca":true},{"name":"Zuocheng Wang","is_ca":true},{"name":"Jiuchang Zhong","is_ca":false},{"name":"Gavin Y. Oudit","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05245593690220392,"gpt":0.3157799530829468,"spread":0.2633240161807429,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.001005189,0.001908519,0.006432063,0.0008457658,0.0002678195,0.0005303121,0.0004034999,0.0007267777,0.00005488965],"category_scores_gemma":[0.00005011347,0.001306464,0.001384934,0.001362993,0.0004439251,0.001172369,0.0002267879,0.001413726,0.0001223066],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004058707,"about_ca_system_score_gemma":0.001078128,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003991837,"about_ca_topic_score_gemma":0.0002818702,"domain_scores_codex":[0.9929695,0.0007892731,0.001997387,0.001430956,0.001073013,0.001739937],"domain_scores_gemma":[0.9962448,0.0006724602,0.001059167,0.001457681,0.0002909666,0.0002749529],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002573498,0.003502857,0.03180809,0.06792472,0.04812223,0.00489598,0.02948713,0.000659332,0.002038425,0.02559334,0.02120114,0.7621933],"study_design_scores_gemma":[0.001868956,0.000171175,0.004738888,0.03742642,0.008338658,0.002020347,0.003747672,0.00004190949,0.000108783,0.0001051135,0.9391419,0.002290237],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001901481,0.9923165,0.00008305282,0.001058235,0.0007521973,0.002679372,0.00004654815,0.0002784479,0.0008841279],"genre_scores_gemma":[0.1588095,0.8331568,0.002239889,0.0006283729,0.002135117,0.0002658903,0.0003329964,0.0007173789,0.001714142],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9179407,"threshold_uncertainty_score":0.9993659,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2055678521","doi":"10.1016/j.ddstr.2008.10.001","title":"Cognitive enhancing drugs for schizophrenia","year":2008,"lang":"en","type":"article","venue":"Drug Discovery Today Therapeutic Strategies","topic":"Receptor Mechanisms and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary; Foothills Medical Centre","funders":"","keywords":"Schizophrenia (object-oriented programming); Cognition; Psychology; Dopamine; Dopamine hypothesis of schizophrenia; Neuroscience; Medicine; Psychiatry; Dopamine receptor D2","authors":[{"name":"Thomas J. Raedler","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01668047938715617,"gpt":0.2651454815594377,"spread":0.2484650021722816,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000181207,0.0002571272,0.0002222372,0.00004597819,0.0002926512,0.0001277948,0.0001876161,0.0001141825,0.00007456572],"category_scores_gemma":[0.00001966225,0.0002285388,0.0002012371,0.00007757523,0.0001242925,0.00003855138,0.00004439915,0.00009384149,0.00001404899],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001262108,"about_ca_system_score_gemma":0.0002692851,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002032889,"about_ca_topic_score_gemma":0.00002079498,"domain_scores_codex":[0.9987187,0.00005805641,0.0002516885,0.0004413838,0.0001631208,0.0003669991],"domain_scores_gemma":[0.9994492,0.0000737176,0.00009970028,0.0002162212,0.0001006,0.00006055195],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0006331458,0.00007341842,0.00005834575,0.00003153588,0.000205174,0.000003115455,0.001057712,0.0001316437,0.9882924,0.006240507,0.0002939558,0.002979079],"study_design_scores_gemma":[0.001365807,0.0002601165,0.0001473723,0.00005046419,0.0000490579,0.00001852816,0.007853736,0.00006348891,0.9806434,0.004313136,0.004801991,0.0004329283],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9369671,0.001880785,0.05757013,0.00006591849,0.0004017081,0.0005143286,0.00005810244,0.00003493506,0.00250704],"genre_scores_gemma":[0.9958479,0.0004021783,0.0004798145,0.0003384049,0.0004448596,0.0001601111,0.000166249,0.00004640946,0.002114063],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05888086,"threshold_uncertainty_score":0.9319543,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}